MYP_158834
E1P41-1
Antimicrobial
Antiviral
▸
Anti-HIV
▸
Antiviral
▸
Antiviral mechanism
▸
Standard
18 amino acids
C117H152N28O31
Standard
KWESEFWRWTEQLASNYW
2446.63 Da
4.79
-1.23
-1.44
-0.0685
-1.37
0.60
-0.11
69.96
27.22
0.3333
23490.00
23490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
988.10
-4.71
36.0
30.0
74.0
176.0
10.0
19.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0070436
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial
Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells
66.7±20.2 μM
IC50
RECORD: Rec_0113628
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Aurein
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
HIV-1 NL4-3
66.7±20.2 μM
IC50
RECORD: Rec_0341883
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Anti-HIV-1
Fusion inhibition
HIV-1 NL4-3 | TZM-bl cells
66.7±20.2 μM
IC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min